Company Description
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.
It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices.
In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection.
Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products.
The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.
Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
| Country | United States |
| Founded | 1989 |
| IPO Date | Aug 16, 1995 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3,946 |
| CEO | Jan De Witte |
Contact Details
Address: 1100 Campus Road Princeton, New Jersey 08540 United States | |
| Phone | 609 275 0500 |
| Website | integralife.com |
Stock Details
| Ticker Symbol | IART |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000917520 |
| CUSIP Number | 457985208 |
| ISIN Number | US4579852082 |
| Employer ID | 51-0317849 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Jan De Witte | President, Chief Executive Officer and Director |
| Dr. Stuart M. Essig Ph.D. | Executive Chairman |
| Lea Daniels Knight | Executive Vice President and Chief Financial Officer |
| Jeffrey A. Mosebrook | Senior Vice President of Finance and Principal Accounting Officer |
| Robert T. Davis Jr. | Executive Vice President and President of Tissue Technologies |
| Michael J. McBreen | Executive Vice President and President of Codman Specialty Surgical |
| Stephen Leonard | Corporate Vice President of Global Operations and Supply Chain |
| Laurene Isip | Vice President of Global Corporate Communications and Public Relations |
| Ruth L. Fleming | Vice President of Global Marketing |
| Chantal Veillon-Berteloot | Executive Vice President and Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 4, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 4, 2024 | 10-Q | Quarterly Report |
| Nov 4, 2024 | 8-K | Current Report |
| Nov 4, 2024 | 8-K | Current Report |
| Aug 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jul 29, 2024 | 10-Q | Quarterly Report |
| Jul 29, 2024 | 8-K | Current Report |
| Jul 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |